Quick Answer
BIODESIX INC reported Total Revenue of $88.50 million for the year ending 2025.
- BIODESIX INC showed an increase of +24.1% in Total Revenue from 2024 to 2025.
- This data is from BIODESIX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $3.94 million | Q1 2020: $5.10 million | Q2 2020: $4.24 million | Q3 2020: $9.19 million | Q1 2021: $28.87 million | Q2 2021: $11.89 million | Q3 2021: $6.53 million | Q1 2022: $6.55 million | Q2 2022: $10.95 million | Q3 2022: $11.11 million | Q1 2023: $9.06 million | Q2 2023: $11.87 million | Q3 2023: $13.49 million | Q1 2024: $14.82 million | Q2 2024: $17.93 million | Q3 2024: $18.15 million | Q1 2025: $17.96 million | Q2 2025: $20.02 million | Q3 2025: $21.77 million.
- Over the full 7 years of available data (2019 to 2025), BIODESIX INC's Total Revenue has grown by 260.5%.
- Historical annual values: Fiscal year 2025: $88.50 million | Fiscal year 2024: $71.32 million | Fiscal year 2023: $49.09 million | Fiscal year 2022: $38.21 million | Fiscal year 2021: $54.51 million | Fiscal year 2020: $45.56 million | Fiscal year 2019: $24.55 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: